The primary role of the Mouse Genetics Core Facility (MGCP) Is to facilitate the use of mouse molecular genetics at MSKCC for in vivo studies of gene functions germane to cancer. Relevant fields where mouse models can be applied include cell growth and behavior, cellular differentiation, embryonic development, immunobiology, genome integrity, and malignant transformation. The MGCP consists of 3 groups: the Transgenic Mouse Group, the Colony Management Group, and the ES Cell Culture Group. Some of the services these groups provide are: (1) Production of transgenic mice: transgene DNA purification, pronuclear injection, genotyping of founder mice, and breeding of positive founders to provide Gl progeny. (2) Gene Targeting: electroporation of gene targeting vector into ES cells, selection and identification of clones, and cryopreservation of targeted ES cell clones. (3) Production of gene targeted mice: generation of chimeric mice by blastocyst Injection and identification of germline chimeras. (4) Long term storage of mouse strains by cryopreservation of sperm or embryos. (5) Rederivation by embryo transfer or IVF for strain importation and recovery. (6) Performance of specialized animal surgical procedures and embryological techniques. (7) Provision of specialized mouse strains/lines for investigators' research. (8) Comprehensive management of research animal colonies for investigators. (9) Genotyping of transgenic, gene targeted, and mutant mouse lines. The services provided by the Mouse Genetics Core has supported the research of 74 investigators in the past year. During the past grant period the work of the Core has contributed to 241 publications of researchers from 8 research programs. For example, the Core provided services to study the relationship between genome integrity and cancer. The Core carried out ES cell injections for the derivation of novel mouse strains in which certain facets of the DNA damage response are impaired by mutation affecting the Mre11 complex, the apical sensor of DNA damage mammals. Collectively, the data obtained led to the publication of work that described the central role of the Mre11 complex in tumor suppression by the DNA damage response.

Public Health Relevance

The MGCP provides a comprehensive and interconnected set of services that are essential to the production, management and preservation of genetically modified mice at MSKCC. These services enable Center investigators to establish animal models suitable for studies on a wide range of problems relevant to cancer biology, such as the genetic basis of oncogenesis and metastasis, as well as problems applicable to therapeutics such as the evaluation of new drugs and drug targets.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-50
Application #
8986758
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
50
Fiscal Year
2016
Total Cost
$901,798
Indirect Cost
$394,315
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Pulitzer, Melissa; Geller, Shamir; Kumar, Erica et al. (2018) T-cell receptor-? expression and ??+ T-cell infiltrates in primary cutaneous ?? T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology 73:653-662
Geller, Shamir; Dickson, Mark A; Busam, Klaus J et al. (2018) Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment. J Oncol Pract 14:565-568
Brand, Christian; Sadique, Ahmad; Houghton, Jacob L et al. (2018) Leveraging PET to image folate receptor ? therapy of an antibody-drug conjugate. EJNMMI Res 8:87
Jiang, Jue; Hu, Yu-Chi; Tyagi, Neelam et al. (2018) Tumor-aware, Adversarial Domain Adaptation from CT to MRI for Lung Cancer Segmentation. Med Image Comput Comput Assist Interv 11071:777-785
Cifani, Paolo; Dhabaria, Avantika; Chen, Zining et al. (2018) ProteomeGenerator: A Framework for Comprehensive Proteomics Based on de Novo Transcriptome Assembly and High-Accuracy Peptide Mass Spectral Matching. J Proteome Res 17:3681-3692
Ito, Kimiteru; Schöder, Heiko; Teng, Rebecca et al. (2018) Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy. Eur J Nucl Med Mol Imaging :
Shah, Gunjan L; Scordo, Michael; Kosuri, Satyajit et al. (2018) Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:142-149
Abraham, Ann; Zhang, Alysandra J; Ahn, Rosa et al. (2018) Media Content Analysis of Marijuana's Health Effects in News Coverage. J Gen Intern Med 33:1438-1440
Maiga, Amelia W; Deppen, Stephen A; Mercaldo, Sarah Fletcher et al. (2018) Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules. JAMA Surg 153:329-334
Raj, Nitya; Reidy-Lagunes, Diane (2018) The Role of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography in Well-Differentiated Neuroendocrine Tumors: A Case-Based Approach Illustrates Potential Benefits and Challenges. Pancreas 47:1-5

Showing the most recent 10 out of 8799 publications